High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$32.4M
$32,400,176
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
IONS
M
IONIS PHARMACEUTICALS INC
Jenne Kyle
• Officer • EVP, Chf GL Pdt Str Ofcr
Other
2026-03-10
$1,665,128Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf GL Pdt Str Ofcr
Other
|
2026-03-10 | $1,665,128Largex2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Jenne Kyle
• Officer • EVP, Chf GL Pdt Str Ofcr
10b5-1 SellΔOwn -43.2%
2026-03-10
$2,827,325Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chf GL Pdt Str Ofcr
10b5-1 SellΔOwn -43.2%
|
2026-03-10 | $2,827,325Largex2 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
Other
|
2026-03-10 | $2,076,532Large | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 Sell
|
2026-03-10 | $2,589,144Largex2 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
Other
|
2026-03-09 | $6,962,832Whalex2 | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CEO
10b5-1 Sell
|
2026-03-09 | $9,525,011Whalex3 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
O'NEIL PATRICK R.
• Officer • EVP CLO & General Counsel
10b5-1 SellΔOwn -14.0%
2026-03-09
$763,662
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP CLO & General Counsel
10b5-1 SellΔOwn -14.0%
|
2026-03-09 | $763,662 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
Other
2026-03-04
$20,066x2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
Other
|
2026-03-04 | $20,066x2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
10b5-1 Sell
2026-03-04
$35,120x2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
10b5-1 Sell
|
2026-03-04 | $35,120x2 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
Other
|
2026-03-04 | $7,612 | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-03-04 | $16,000 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
Other
2026-03-03
$75,215x2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
Other
|
2026-03-03 | $75,215x2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Baroldi Joseph
• Officer • EVP, Chief Business Officer
10b5-1 Sell
2026-03-03
$495,867x3
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Business Officer
10b5-1 Sell
|
2026-03-03 | $495,867x3 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
BENNETT C FRANK
• Officer • EVP, Chief Scientific Officer
Other
2026-03-03
$3,497,531Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Scientific Officer
Other
|
2026-03-03 | $3,497,531Largex2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
BENNETT C FRANK
• Officer • EVP, Chief Scientific Officer
10b5-1 Sell
2026-03-03
$6,741,669Whalex3
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Scientific Officer
10b5-1 Sell
|
2026-03-03 | $6,741,669Whalex3 | S | Form 4 |
|
IONS
M
IONIS PHARMACEUTICALS INC
Devers Shannon L.
• Officer • EVP, Chief Human Resources Ofc
Other
2026-03-03
$723,254x5
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Human Resources Ofc
Other
|
2026-03-03 | $723,254x5 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Devers Shannon L.
• Officer • EVP, Chief Human Resources Ofc
10b5-1 Sell
2026-03-03
$1,596,433Largex3
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP, Chief Human Resources Ofc
10b5-1 Sell
|
2026-03-03 | $1,596,433Largex3 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
Other
|
2026-03-03 | $1,601,607Largex3 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Diaz Allene M.
• Director
10b5-1 SellΔOwn -20.9%
2026-03-03
$4,354,428Largex3
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 SellΔOwn -20.9%
|
2026-03-03 | $4,354,428Largex3 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
Other
|
2026-03-03 | $652,120x2 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
KLEIN JOSEPH III
• Director
10b5-1 Sell
2026-03-03
$1,696,181Largex3
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-03-03 | $1,696,181Largex3 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
Other
|
2026-03-03 | $31,666 | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-03-03 | $66,833 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Swayze Eric
• Officer • EVP Research
10b5-1 SellΔOwn -16.2%
2026-02-13
$1,278,914Largex2
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Officer • EVP Research
10b5-1 SellΔOwn -16.2%
|
2026-02-13 | $1,278,914Largex2 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 Sell
|
2026-02-11 | $413,588 | S | Form 4 |